Preparation and evaluation of ketoprofen floating oral delivery system

被引:110
作者
El-Kamel, AH [1 ]
Sokar, MS [1 ]
Al Gamal, SS [1 ]
Naggar, VF [1 ]
机构
[1] Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt
关键词
ketoprofen; floating microparticles; Eudragit; emulsion solvent diffusion; sustained release;
D O I
10.1016/S0378-5173(01)00574-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A sustained release system for ketoprofen designed to increase its residence time in the stomach without contact with the mucosa was achieved through the preparation of floating microparticles by the emulsion-solvent diffusion technique. Four different ratios of Eudragit S100 (ES) with Eudragit RL (ERL) were used to form the floating microparticles. The drug retained in the floating microparticles decreased with increase in ERL. content. All floating microparticle formulations showed good flow properties and packability. Scanning electron microscopy and particle size analysis revealed differences between the formulations as to their appearance and size distribution. X-ray and DSC examination showed the amorphous nature of the drug. Release rates were generally low in 0.1 N HCl especially in presence of high content of ES while in phosphate buffer pH 6.8. high, amounts of ES tended to give a higher release rate. Floating ability in 0.1 N HCl, 0.1 N HCl containing 0.02% Tween 20 and simulated gastric fluid without pepsin was also tested. The formulation containing ES:ERL1:1 (FIII) exhibited high percentage of floating particles in all examined media. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 20 条
[1]  
ACIKGOZ M, 1995, PHARMAZIE, V50, P275
[2]   INFLUENCE OF MEDIUM ON DISSOLUTION-EROSION BEHAVIOR OF NA CARBOXYMETHYLCELLULOSE AND ON VISCOELASTIC PROPERTIES OF GELS [J].
BONFERONI, MC ;
ROSSI, S ;
FERRARI, F ;
BERTONI, M ;
CARAMELLA, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (01) :41-48
[3]   A FLOATING CONTROLLED-RELEASE DRUG-DELIVERY SYSTEM - IN-VITRO IN-VIVO EVALUATION [J].
DESAI, S ;
BOLTON, S .
PHARMACEUTICAL RESEARCH, 1993, 10 (09) :1321-1325
[4]   Controlled-release drug delivery systems for prolonged gastric residence: An overview [J].
Deshpande, AA ;
Rhodes, CT ;
Shah, NH ;
Malick, AW .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (06) :531-539
[5]  
DOLLERY C, 1999, THERAPEUTIC DRUGS, V2, pK18
[6]   Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study [J].
Iannuccelli, V ;
Coppi, G ;
Bernabei, MT ;
Cameroni, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 174 (1-2) :47-54
[7]  
KAWAKITA K, 1964, ZAIRYO, V13, P421
[8]   HOLLOW MICROSPHERES FOR USE AS A FLOATING CONTROLLED DRUG DELIVERY SYSTEM IN THE STOMACH [J].
KAWASHIMA, Y ;
NIWA, T ;
TAKEUCHI, H ;
HINO, T ;
ITOH, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (02) :135-140
[9]   CONCEPT OF DISSOLUTION EFFICIENCY [J].
KHAN, KA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (01) :48-49
[10]  
KUNO H, 1979, THEORY APPL